{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:42Z","timestamp":1792081542532,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beem.2023.101816","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T21:05:34Z","timestamp":1692219934000},"page":"101816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association?"],"prefix":"10.1016","volume":"37","author":[{"given":"Yutaka","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.beem.2023.101816_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071447","article-title":"The role of growth hormone and insulin-like growth factor-I in the liver","volume":"18","author":"Takahashi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.beem.2023.101816_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib3","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0197","article-title":"The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy","volume":"257","author":"Ho","year":"2023","journal-title":"J Endocrinol"},{"issue":"26","key":"10.1016\/j.beem.2023.101816_bib4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Melmed","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1210\/jc.2012-4012","article-title":"Idiopathic adult growth hormone deficiency","volume":"98","author":"Melmed","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101816_bib8","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"10290","key":"10.1016\/j.beem.2023.101816_bib10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"issue":"30","key":"10.1016\/j.beem.2023.101816_bib12","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1074\/jbc.M109.014308","article-title":"Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism","volume":"284","author":"Fan","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.beem.2023.101816_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI42894","article-title":"Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2","volume":"121","author":"Sos","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep.21713","article-title":"Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration","volume":"46","author":"Cui","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.beem.2023.101816_bib15","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.2337\/db16-0649","article-title":"Growth hormone control of hepatic lipid metabolism","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.beem.2023.101816_bib16","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/db15-0370","article-title":"Growth hormone inhibits hepatic de novo lipogenesis in adult mice","volume":"64","author":"Cordoba-Chacon","year":"2015","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.beem.2023.101816_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102532","article-title":"Towards understanding the direct and indirect actions of growth hormone in controlling hepatocyte carbohydrate and lipid metabolism","volume":"10","author":"Vazquez-Borrego","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.beem.2023.101816_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad375","article-title":"Growth hormone administration improves nonalcoholic fatty liver disease in overweight\/obesity: a randomized trial","author":"Dichtel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ghir.2010.02.002","article-title":"The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency","volume":"20","author":"Deepak","year":"2010","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"10.1016\/j.beem.2023.101816_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-014-0621-6","article-title":"Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly","volume":"18","author":"Ozkan","year":"2015","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.1901330","article-title":"Growth hormone reprograms macrophages toward an anti-inflammatory and reparative profile in an MAFB-dependent manner","volume":"205","author":"Soler Palacios","year":"2020","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.celrep.2017.03.046","article-title":"IGF1 shapes macrophage activation in response to immunometabolic challenge","volume":"19","author":"Spadaro","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2012.05.115","article-title":"GH-independent IGF-1 action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model.","volume":"423","author":"Nishizawa","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.beem.2023.101816_bib24","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1038\/srep34605","article-title":"IGF-1 induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.","volume":"6","author":"Nishizawa","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.23412","article-title":"Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats","volume":"51","author":"Sobrevals","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.beem.2023.101816_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-5-7","article-title":"Antioxidant effects of insulin-like growth factor-I (IGF-1) in rats with advanced liver cirrhosis","volume":"5","author":"Garcia-Fernandez","year":"2005","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib27","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2023.101816_bib28","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/clinem\/dgac088","article-title":"Growth hormone and insulin-like growth factor 1 regulation of nonalcoholic fatty liver disease","volume":"107","author":"Dichtel","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/adc.76.6.537","article-title":"Effect of growth hormone on fatty liver in panhypopituitarism","volume":"76","author":"Takano","year":"1997","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1507\/endocrj.49.597","article-title":"Adult growth hormone deficiency in Japan: results of investigation by questionnaire","volume":"49","author":"Kaji","year":"2002","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/gut.52.6.914","article-title":"Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency","volume":"52","author":"Ichikawa","year":"2003","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.beem.2023.101816_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1507\/endocrj.K08E-079","article-title":"Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature","volume":"55","author":"Fukuda","year":"2008","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2006.12.024","article-title":"Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency","volume":"132","author":"Takahashi","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2023.101816_bib34","doi-asserted-by":"crossref","first-page":"8814435","DOI":"10.1155\/2020\/8814435","article-title":"Characteristics of NAFLD based on hypopituitarism","volume":"2020","author":"Kodama","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-15-0422","article-title":"Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101816_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ghir.2014.07.002","article-title":"Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency","volume":"24","author":"Matsumoto","year":"2014","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.beem.2023.101816_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cen.13042","article-title":"Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement","volume":"85","author":"Meienberg","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101816_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/hep.20140","article-title":"Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction","volume":"39","author":"Adams","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.beem.2023.101816_bib39","first-page":"99","article-title":"Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases","volume":"39","author":"Yang","year":"2018","journal-title":"Neuro Endocrinol Lett"},{"issue":"8","key":"10.1016\/j.beem.2023.101816_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1651-2227.2000.tb00415.x","article-title":"Investigation and outcome of neonatal hepatitis in infants with hypopituitarism","volume":"89","author":"Spray","year":"2000","journal-title":"Acta Paediatr"},{"issue":"8","key":"10.1016\/j.beem.2023.101816_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/petr.12819","article-title":"Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism","volume":"20","author":"Gilliland","year":"2016","journal-title":"Pedia Transpl"},{"issue":"12","key":"10.1016\/j.beem.2023.101816_bib42","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2169\/internalmedicine.0027-17","article-title":"Hormone-replacement therapy for hepatopulmonary syndrome and NASH associated with hypopituitarism","volume":"57","author":"Torii","year":"2018","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.beem.2023.101816_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/hep4.1953","article-title":"Growth hormone deficiency and NAFLD: an overlooked and underrecognized link","volume":"6","author":"Doycheva","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.beem.2023.101816_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.6065\/apem.2018.23.1.51","article-title":"Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report","volume":"23","author":"Jung","year":"2018","journal-title":"Ann Pedia Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101816_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.6065\/apem.2017.22.3.189","article-title":"Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma","volume":"22","author":"Jung","year":"2017","journal-title":"Ann Pedia Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101816_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846880","article-title":"Treatment of acquired hypothalamic obesity: now and the future","volume":"13","author":"Dimitri","year":"2022","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2023.101816_bib47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.dld.2007.11.011","article-title":"Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial","volume":"40","author":"Li","year":"2008","journal-title":"Dig Liver Dis"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:29Z","timestamp":1761497969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521690X23000908"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101816","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101816"}}